Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
30 hedge funds and large institutions have $386M invested in Sinovac Biotech, Ltd in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
3% more funds holding
Funds holding: 29 → 30 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
60% less capital invested
Capital invested by funds: $961M → $386M (-$575M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FGAM
Financial Gravity Asset Management
Lakeway,
Texas
|
+$3.2M |
| 2 |
Morgan Stanley
New York
|
+$15K |
| 3 |
YMRC
Yorktown Management & Research Company
Forest,
Virginia
|
+$2.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$39 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $340M | – | – | – |
|
|
VC
2
Vivo Capital
Palo Alto,
California
| $38.2M | – | – | – |
|
|
FGAM
3
Financial Gravity Asset Management
Lakeway,
Texas
| $3.2M | +$3.2M | +988 | New |
|
|
NAH
4
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M | – | – | – |
|
5
Renaissance Technologies
New York
| $1.54M | – | – | – |
|
6
State Street
Boston,
Massachusetts
| $1.04M | – | – | – |
|
7
Geode Capital Management
Boston,
Massachusetts
| $179K | – | – | – |
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $58.8K | – | – | – |
|
|
10
Morgan Stanley
New York
| $44.5K | +$15K | +2,313 | +51% |
|
11
JP Morgan Chase
New York
| $19.4K | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $10.7K | – | – | – |
|
|
YMRC
13
Yorktown Management & Research Company
Forest,
Virginia
| $4.49K | +$2.25K | +74,893 | +100% |
|
14
Group One Trading
Chicago,
Illinois
| $2.67K | – | – | – |
|
|
15
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $660 | -$39 | -6 | -6% |
|
|
HI
16
Horizon Investments
Charlotte,
North Carolina
| $336 | – | – | – |
|
SVA Hedge Fund Activity: Q3 2023 in Review
30 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q3 2023, worth a combined $386M — down 60% from $961M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SVA positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Financial Gravity Asset Management, opening a new position worth an estimated $3.2M. The largest seller was Northwestern Mutual Wealth Management, cutting an estimated $39.
- 30 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q3 2023, up from 29 in Q2 2023.
- Funds reported $386M of Sinovac Biotech, Ltd stock for Q3 2023, down 60% quarter-over-quarter.
- 1 fund opened new Sinovac Biotech, Ltd positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Sinovac Biotech, Ltd buyer in Q3 2023 was Financial Gravity Asset Management, an estimated $3.2M added.
- The largest Sinovac Biotech, Ltd seller in Q3 2023 was Northwestern Mutual Wealth Management, an estimated $39 sold.
Based on aggregated 13F filings for Q3 2023.